Please assess the completion status of the following clinical trial:

Trial Title: Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with measurable per Response Evaluation Criteria in Solid Tumors (RECIST) criteria 1.1 and biopsy-able (as determined by Co-Investigator John Gemery, MD) metastatic carcinoma of the breast.~* Physically able to undertake a moderate physical activity program.~* Greater than 4 weeks from any radiation treatments for metastatic disease.~* standard of care biopsy must occur within 30 days of registration.~* Able to follow directions and fill out questionnaires and physical activity diaries in English.~* Willing to consent to biopsies and be randomly assigned to one of two study arms which may or may not include physical activity goal setting.~* Consents to be contacted via phone or internet (see Appendix K).~* No to all questions on Physical Activity Readiness Questionnaire (see appendix A) or approved by primary oncologist or other care provider provider for participation.~* Hb \>10 without transfusion, liver function tests less than 3 times upper limits of normal, normal thyroid-stimulating hormone (TSH), absolute neutrophil count (ANC) \>1500.~* Karnofsky performance status ≥ 80%~* Previous Physical Therapy consultation and treatments acceptable.~* Participation in other trials acceptable.~* CNS disease that is treated and stable by MRI for at least 6 months~Exclusion Criteria:~* Patients less than 18 years of age.~* Patients unable to give informed consent indicating they are aware of the investigational nature of this treatment, prior to entry into the study.~* Pregnant or nursing women.~* Patients with any untreated (CNS) disease.~* Patients with other active cancers requiring treatment.~* Patients with clotting or bleeding disorder precluding biopsy.~* Patients with significant cardiovascular disease, including uncontrolled high blood pressure, unstable angina, congestive heart failure, myocardial infarction within the previous 6 months or serious cardiac arrhythmias will be excluded.~* Current use of supplements containing conjugated linoleic acid, or use within the 30 days preceding registration.~* Persons with a known diagnosis of diabetes are not eligible. Prior use of metformin allowable if previously enrolled on MA.32 trial as part of their adjuvant therapy for early stage breast cancer.~* Persons of male gender.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Arm A-Pedometer and Goal setting (Type: EXPERIMENTAL): Physical Activity Goal Setting~Patients receive physical therapy (PT) consult, educational materials, and telephone calls and are contacted weekly/monthly for physical activity (PA) goal setting with registered nurse (RN). Physical Activity completed is measured with pedometers and recorded on patient log.
- ARM B (Type: NO_INTERVENTION): Patients receive standard physical activity recommendations and follow up.

Based on this trial design, predict the completion outcome and termination type (if applicable).